Login / Signup

Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn's Disease: A Multi-Center Retrospective Cohort Study.

Ahmad AlbsheshLian BannonTali Sharar FischlerMarie TruyensStephan R VavrickaKatja TepesDaniela PuglieseEdoardo Vincenzo SavarinoEran ZittanDavid DrobneXavier RoblinAriella Bar-Gil ShitritAlessandro ArmuzziTriana LobatonNitsan MaharshakHenit YanaiShomron Ben-HorinUri Kopylov
Published in: Journal of clinical medicine (2023)
Second-line biological therapy after VDZ failure therapy was effective in >60% of the patients with CD. No differences in effectiveness were detected between the use of anti-TNF and UST as a second line.
Keyphrases
  • randomized controlled trial
  • rheumatoid arthritis
  • systematic review
  • stem cells
  • cell therapy
  • smoking cessation